ClinicalTrials.gg

Drug

Melphalan hydrochloride clinical trials

Also written Evomela and HEPZATO.

A product of Melphalan; its studies count on that page too.

studies test it
12
open now
1
in phase 3
2
first study started
2011

Keep track of what changes. Save the melphalan hydrochloride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

12 studies that test it; most in 2018 (3)

Studies that test melphalan hydrochloride, by start year
YearStudies
20111
20131
20141
20161
20172
20183
20191
20221
20231

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
8
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 1 · Other 11

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Roswell Park Cancer Institute (1) · Delcath Systems Inc. (1) · Medical College of Wisconsin (1) · M.D. Anderson Cancer Center (1) · University of Washington (1) · Washington University School of Medicine (1) · Children's Oncology Group (1)

Often tested with

Tested in the same studies.

Fludarabine (3) · Fludarabine phosphate (2) · Cytarabine (2) · Cyclophosphamide (1) · Cladribine (1) · Cyclosporine (1) · Filgrastim (1) · Mitoxantrone (1)

Studies

Open first, then newest update. How each study uses melphalan hydrochloride is read from its arms, and is right about nine times in ten.

Testing it · 12

Given in every arm · 1 — melphalan hydrochloride is usual care beside what is tested

Codes

What other systems call melphalan hydrochloride · ClinicalTrials.gg INT014359

  • RxNorm 235857One source FDA
  • Wikidata Q27252967melphalan hydrochlorideOne source Wikidata
  • NCI Thesaurus C48002Melphalan HydrochlorideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.